Loading…
High‐performance countercurrent membrane purification for host cell protein removal from monoclonal antibody products
The transition to continuous biomanufacturing has led to renewed interest in alternative approaches for downstream processing of monoclonal antibody (mAb) products. In this study, we examined the potential of using high‐performance countercurrent membrane purification (HPCMP) for the removal of host...
Saved in:
Published in: | Biotechnology and bioengineering 2023-12, Vol.120 (12), p.3585-3591 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The transition to continuous biomanufacturing has led to renewed interest in alternative approaches for downstream processing of monoclonal antibody (mAb) products. In this study, we examined the potential of using high‐performance countercurrent membrane purification (HPCMP) for the removal of host cell proteins (HCPs) derived from Chinese Hamster Ovary cells in the purification of a mAb. Initial studies used several model proteins to identify appropriate operating conditions for the hollow fiber membrane modules. HPCMP was then used for mAb purification, with mAb yield >95% and more than 100‐fold reduction in HCP. Stable operation was maintained for 48 h for feeds that were first prefiltered through the 3MTM Harvest RC chromatographic clarifier to remove DNA and other foulants. In addition, the Process Mass Intensity for HPCMP can be much less than that for alternative HCP separation processes. These results highlight the potential of using HPCMP as part of a fully continuous mAb production process.
High Performance Countercurrent Membrane Purification (HPCMP) was successfully used for Host Cell Protein (HCP) removal in monoclonal antibody (mAb) purification with |
---|---|
ISSN: | 0006-3592 1097-0290 |
DOI: | 10.1002/bit.28531 |